Rezolute (RZLT)
(Delayed Data from NSDQ)
$5.69 USD
-0.17 (-2.90%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $5.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RZLT 5.69 -0.17(-2.90%)
Will RZLT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RZLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RZLT
Rezolute (RZLT) Upgraded to Buy: What Does It Mean for the Stock?
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing
RZLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?
Here's Why 'Trend' Investors Would Love Betting on Rezolute (RZLT)
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
Other News for RZLT
Rezolute to Participate in the BTIG Virtual Biotechnology Conference | RZLT Stock News
Rezolute files to sell 1.3M shares of common stock for holders
Rezolute (RZLT) Announces Sale of 1.3 Million Common Stock Shares | RZLT Stock News
Rezolute files to sell 1.3M shares of common stock for holders
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 ...